Mental Health Archive — Page 1 of 13

Circular teal and dark purple badge reading “ALL IN Wellbeing First for Healthcare,” “Wellbeing First,” “CHAMPION,” “2026,” and “Licensing and Credentialing,” with two white stars.
October 29, 2026

Vanderbilt Health recognized for support of employees’ mental well-being

The Dr. Lorna Breen Foundation’s “Wellbeing First Champion” award focuses on institutions that protect and advocate for employees.

Logo reading “KeTADiD” and “Ketamine for Treatment of Alzheimer’s Disease related Depression,” with a stylized puzzle-piece brain, IV bag, and leaves inside a circular gradient design.
October 22, 2026

Researchers recruiting adults with depression and early Alzheimer’s disease for IV Ketamine study

The KeTADiD study, which will start enrolling in December, is funded by the Alzheimer’s Association.

Unidentified pregnant person in a black top holds a handful of assorted pills while resting the other hand on their abdomen.
October 19, 2026

Study advances understanding of SSRI use during pregnancy

“One of the takeaways (of this study) was that if you need to be on an SSRI, stay on it, but make sure to deliver in a place that can take care of the baby,” said Jennifer Sucre, MD, co-corresponding author of the study.

(iStock)
October 1, 2026

Vanderbilt Memory and Alzheimer’s Center launches this year’s Tennessee Dementia ECHO program connecting health care professionals with dementia care experts

Since its launch in 2024, the program has expanded to serve clinicians across West, Middle and East Tennessee through regional partnerships with the University of Memphis and the University of Tennessee at Chattanooga.

A. Compared to healthy individuals, psychosis subtype 1 demonstrated significantly larger surface area across the cortex and larger basal ganglia volumes. B. Compared to healthy individuals, psychosis subtype 2 demonstrated widespread lower surface area and cortical thickness, and smaller subcortical volumes. (Hill, L.D., et al. Subtyping psychotic disorders using a data-driven approach reveals divergent cortical and cellular signatures. Mol Psychiatry (2026). https://doi.org/10.1038/s41380-026-03774-2. Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0/. Rights and Permissions: https://tinyurl.com/2e9nxeah.)
August 27, 2026

Brain scan method may improve diagnosis, treatment of psychosis

The study suggests that heterogeneity, or the wide range of symptoms, treatment responses and long-term outcomes observed in patients with various forms of psychosis, may reflect separate illness mechanisms and developmental pathways.

White tablets scattered beside two blue injection pens on a blue surface.
August 18, 2026

Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling

The study, Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder (TAB), is a double-blind, randomized, placebo-controlled trial conducted through the National Institute on Drug Abuse’s Clinical Trials Network.